Guangdong Marubi Biotechnology Co., Ltd.SSE: 603983

2024 Annual Report

Apr 26, 2025 · Issued by Guangdong Marubi Biotechnology Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 26, 2025

On 6ix: 6ix.com/news/2024-annual-report-130

2024 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Guangdong Marubi Biotechnology Co., Ltd. on 6ix

Earlier from Guangdong Marubi Biotechnology

Announcement on Redemption at Maturity of Financial Products Purchased by Using Idle Raised Funds and Continuing PurchaseMar 21, 2025
Announcement on Redemption at Maturity of Financial Products Purchased by Using Idle Raised FundsDec 14, 2024
Announcement on Completion of Industrial and Commercial Change RegistrationDec 12, 2024
Announcement on the Implementation of the Change of Securities AbbreviationDec 9, 2024
Announcement on the Proposed Change of Securities AbbreviationDec 6, 2024

Later from Guangdong Marubi Biotechnology

Notice on Convening the 2024 Annual General MeetingMay 1, 2025
Announcement on Resolution of the 2024 Annual General MeetingMay 23, 2025
Announcement on Implementation of Dividend Distribution for 2024Jun 4, 2025
Announcement on Reply to Letter of Inquiry on Information Disclosure of 2024 Annual ReportJun 28, 2025
Announcement on Using Partial Idle Raised Funds for Cash ManagementAug 23, 2025

All Guangdong Marubi Biotechnology news releases

Follow Guangdong Marubi Biotechnology into a list and get an email when it puts out news.

Follow Guangdong Marubi Biotechnology